Latest Announcements

BSE & NSE corporate filings with AI summaries

BSECompany Update▲ PositiveRegulatory4 Oct 2026

The Anup Engineering Ltd

The Hon'ble Appellate Authority vide its Order has allowed the appeal filed by Company and set aside the impugned order passed by GST Department hence there is no impact on financials.

The Anup Engineering Ltd has received a favorable order from the Hon'ble Appellate Authority, setting aside a demand from the Gujarat Goods and Service Tax (GST) Department. The order has no impact on the company's financials.

Read more →📎 1 attachment
BSEGeneralRegulatory3 Oct 2026

PFL Infotech Ltd

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>PFL Infotech Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L72200TG1993PLC007005</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable (in ....

PFL Infotech Ltd has confirmed that it does not meet the criteria to be classified as a Large Corporate, as per SEBI and BSE circulars, and therefore does not require additional disclosure requirements.

Read more →📎 1 attachment
BSECompany UpdateRegulatory3 Oct 2026

PFL Infotech Ltd

Compliances Certificate under Res.74(5).

PFL Infotech Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories & Participants) Regulations, 2018, confirming the dematerialization and rematerialization of shares through NSDL & CDSL from July 1, 2026 to September 30, 2026.

Read more →📎 1 attachment
BSEGeneralRegulatory3 Oct 2026

Transgene Biotek Ltd

Compliance -57(4)

Transgene Biotek Ltd has informed BSE that Regulation 57 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 is not applicable to the company as there are no non-convertible securities for which interest/dividend/principal is payable during the quarter.

Read more →📎 1 attachment
BSECompany UpdateRegulatory3 Oct 2026

Aashka Hospitals Ltd

Clarification Letter

Aashka Hospitals Ltd has issued a clarification letter to BSE regarding significant price movement in its script, stating that the movement is market-driven and the company has no control or knowledge of the reasons.

Read more →📎 1 attachment
BSECompany UpdateRegulatory3 Oct 2026

NLC India Ltd

Please refer the attachment.

NLC India Ltd has submitted a compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming the listing of dematerialized shares, cancellation of mutilated certificates, and furnishing of dematerialization/rematerialization details to stock exchanges.

Read more →📎 1 attachment
BSEGeneralRegulatory3 Oct 2026

Transgene Biotek Ltd

<b>Format of Initial Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''><tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> <td><b>Details</b></td> </tr> <tr><td>1</td><td>Name of Company</td><td>Transgene Biotek Ltd</td></tr> <tr><td>2</td><td>CIN NO.</td><td>L85195TG1990PLC011065</td></tr> <tr><td>3</td> <td>Outstanding borrowing of company as on 31st March / 31st December, as applicable ....

Transgene Biotek Ltd has confirmed that it does not fall under the category of 'Large Corporate' as per SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018, and BSE Circular No. LIST/COM/05/2019-20 dated April 11, 2019.

Read more →📎 1 attachment
← PreviousPage 107 of 291Next →